Document Detail

mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis.
MedLine Citation:
PMID:  23044764     Owner:  NLM     Status:  Publisher    
The mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase with a central role in the regulation of cell growth and proliferation, and several intracellular processes, such as mRNA transcription and translation, autophagy and cytoskeletal organization. The relevance of this pathway in the regulation of the immune system is well characterized. mTOR is essential for the proper activation and proliferation of effector T cells, restricts the development of regulatory T cells, and downregulates innate immune responses. Recently, a direct role of mTOR in the modulation of glial functions has also been recognized. Data from our group and others support the notion that mTOR is involved in microglial proinflammatory activation. The kinase regulates several intracellular processes in astrocytes, among which the rate of mRNA degradation of the inducible form of NO synthase. Therefore, the inhibition of mTOR kinase activity in glial cells results in anti-inflammatory actions, suggesting possible beneficial effects of mTOR inhibitors (like rapamycin) in the treatment of inflammatory-based pathologies of the central nervous system. In contrast, mTOR plays an important role in the regulation of oligodendrocyte development and myelination process as well as several neuronal functions, which may limit this therapeutic approach. Nevertheless, as reviewed here, there is robust evidence that rapamycin ameliorates the clinical course of both the relapsing-remitting and the chronic experimental autoimmune encephalomyelitis (EAE), and significantly reduces the hyperalgesia observed before clinical development of EAE. These findings may have important clinical implications for the therapy of multiple sclerosis. © 2012 Wiley Periodicals, Inc.
Cinzia Dello Russo; Lucia Lisi; Douglas L Feinstein; Pierluigi Navarra
Related Documents :
24111984 - The secretogranin ii gene is a signal integrator of glutamate and dopamine inputs.
24817844 - Mice with altered bdnf signaling as models for mood disorders and antidepressant effects.
23598414 - A role for the tyrosine kinase ack1 in neurotrophin signaling and neuronal extension an...
23634894 - Bacillus subtilis serine/threonine protein kinase yabt is involved in spore development...
3954784 - In vitro studies on the reactivation by oximes of phosphylated acetylcholinesterase--ii...
21317884 - The machado-joseph disease deubiquitylase atx-3 couples longevity and proteostasis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-8
Journal Detail:
Title:  Glia     Volume:  -     ISSN:  1098-1136     ISO Abbreviation:  Glia     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8806785     Medline TA:  Glia     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
Institute of Pharmacology, Catholic University Medical School, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Understanding resistant germplasm-induced virulence variation through analysis of proteomics and sup...
Next Document:  Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients w...